Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A collaborative study to establish an international standard for alpha-thrombin.

P J Gaffney1, A B Heath, J W Fenton

  • 1National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, UK.

Thrombosis and Haemostasis
|April 2, 1992
PubMed
Summary

A new international standard for pure alpha-thrombin was established to improve the accuracy of thrombin measurements and inhibitor quantification. This stable, lyophilized preparation (89/588) was assigned a potency of 100 IU per ampoule.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International collaborative study to establish the World Health Organization 2nd International Standard for Fibrinogen Concentrate (09/242): communication from the SSC of the ISTH.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Establishment of the WHO 1st International Standard ADAMTS13, plasma (12/252): communication from the SSC of the ISTH.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Value assignment to the WHO 3rd International Standard for Blood Coagulation Fibrinogen Plasma (09/264): communication from the SSC of the ISTH.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Value assignment of the WHO 8th International Standard for factor VIII, concentrate (07/350).

Journal of thrombosis and haemostasis : JTH·2012
Same author

Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.

Vox sanguinis·2011
Same author

Value assignment of the WHO 6th International Standard for blood coagulation factor VIII and von Willebrand factor in plasma (07/316).

Journal of thrombosis and haemostasis : JTH·2011

Area of Science:

  • Biochemistry
  • Haematology
  • Standardization

Background:

  • An International Standard for thrombin of low purity has been in use since 1975.
  • A need for a pure alpha-thrombin standard emerged for accurate calibration and precise measurement of thrombin inhibitors like hirudin.

Purpose of the Study:

  • To establish the potency and stability of a new ampouled pure alpha-thrombin preparation.
  • To provide a reliable standard for alpha-thrombin measurement and inhibitor quantification.

Main Methods:

  • An international collaborative study was conducted.
  • A clotting-assay procedure was used to determine potency.
  • Stability was assessed at various elevated temperatures.

Main Results:

Related Experiment Videos

  • A potency of 97.5 international units (95% confidence limits 86.5-98.5) was established for the alpha-thrombin standard (89/588).
  • Stability data confirmed no significant loss of potency during transport and storage.
  • The preparation was recommended as an International Standard with an assigned potency of 100 IU per ampoule.

Conclusions:

  • The lyophilized pure alpha-thrombin preparation (89/588) is suitable as an International Standard.
  • This new standard will enhance the accuracy of thrombin calibration and the measurement of thrombin inhibitors.